CFDE Data Portal | Search DSCR4

	Label	Description
	DSCR4 associations Collection (Entity type)	Associations for DSCR4_associations
	DSCR4 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	DSCR4 Gene (Entity type)	ENSG00000184029 - Down syndrome critical region 4
	GSE195663 cisplatin 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216988 GSE216989 decitabine 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE234148 HDAC inhibition 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 15 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 2 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 5 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS

DSCR4 associations

Associations for DSCR4_associations

DSCR4 associations.tsv

A file from IDG as part of the Harmonizome project

DSCR4

ENSG00000184029 - Down syndrome critical region 4

GSE195663 cisplatin 0 v 3 human up

A Gene Set from LINCS

GSE216988 GSE216989 decitabine 0 v 1 human up

A Gene Set from LINCS

GSE234148 HDAC inhibition 0 v 1 human up

A Gene Set from LINCS

GSE225901 dexamethasone 2 v 3 human dn

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 15 v 11 human up

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 2 v 6 human up

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 5 v 6 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.